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Abstract
Objective: The purpose of this study was to determine the prevalence of components of the metabolic
syndrome in adolescents with spinal cord injury (SCI) and spina bifida (SB), and their associations with
obesity in subjects with and without SCI and SB.
Methods: Fifty-four subjects (20 SCI and 34 SB) age 11 to 20 years with mobility impairments from lower
extremity paraparesis were recruited from a hospital-based clinic. Sixty able-bodied subjects who were
oversampled for obesity served as controls (CTRL). Subjects were categorized as obese if their percent trunk
fat measured by dual x-ray absorptiometry (DXA) was .30.0% for males and .35.0% for females. Ten SCI,
24 SB, and 19 CTRL subjects were classified as obese. Fasting serum samples were collected to determine
serum glucose, insulin, and lipid concentrations. Metabolic syndrome was defined as having 3 of the
following components: (a) obesity; (b) high-density lipoprotein (HDL),45 mg/dL for males;,50 mg/dL for
females; (c) triglycerides 100 mg/dL; (d) systolic or diastolic blood pressure 95th percentile for age/
height/gender, and (e) insulin resistance determined by either fasting serum glucose 100–125 mg/dL;
fasting insulin 20lU /mL; or homeostasis model assessment of insulin resistance 4.0.
Results:Metabolic syndrome was identified in 32.4% of the SB group and 55% of the SCI group. Metabolic
syndrome occurred at a significantly higher frequency in obese subjects (SB ¼ 45.8%, SCI¼ 100%, CTRL¼
63.2%) than nonobese subjects (SB ¼ 0%, SCI ¼ 10%, CTRL ¼ 2.4%).
Conclusions: The prevalence of metabolic syndrome in adolescents with SB/SCI is quite high, particularly
in obese individuals. These findings have important implications due to the known risks of cardiovascular
diseases and diabetes mellitus associated with metabolic syndrome in adults, particularly those with spinal
cord dysfunction.
J Spinal Cord Med. 2007;30:S127–S139
Key Words: Spinal cord injuries; Insulin resistance; Metabolic syndrome; Adolescence; Obesity;
Cardiovascular disease
INTRODUCTION
The prevalence of obesity has reached epidemic propor-
tions worldwide (1–3). Obesity is caused by chronic
positive energy balance due to increased energy intake
and/or decreased energy expenditure/physical activity
when combined with a genetic propensity for weight
gain (4,5). Obesity in North American children and
adolescents has tripled within the last twenty years (6),
with a 45% increase in the United States since National
Health and Nutrition Examination Survey (NHANES) III
data were collected in 1994 (7). Based on NHANES
2003–2004, 17.1% of children and adolescents are
95th percentile Body Mass Index for age (6).
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An important consequence of obesity is an increased
prevalence of parameters associated with metabolic
syndrome, a constellation of known risk factors for the
development of type 2 diabetes (8–10), cardiovascular
disease (10–13), and stroke (11,14,15). Metabolic
syndrome has been shown to predict cardiovascular
and coronary heart disease mortality (12,16,17). Obesity
has been implicated as the primary inciting factor of the
metabolic syndrome (18–20). Vanhala et al tracked 439
subjects from childhood to adulthood, and of the 30
adults who were identified with metabolic syndrome,
100% were obese as adults and 75% had been obese as
children (21). Adolescent-onset obesity that persisted
into adulthood increased the potential for lifelong
problems, including increased severity of diseases asso-
ciated with increased weight/adiposity (21).
The central features of metabolic syndrome are
abdominal adiposity, hypertension, increased fasting
glucose concentrations/abnormal glucose tolerance,
and dyslipidemia characterized by increased serum
triglycerides (TG), low serum high-density lipoprotein
(HDL), and/or small dense low-density lipoprotein (LDL)
particles (22). Insulin resistance as evidenced by hyper-
insulinemia appears to be a key feature and may be an
underlying/predisposing factor in the syndrome.
Adolescents with spina bifida (SB) or spinal cord
injury (SCI) have limited mobility and physical activity,
reduced total lean body mass, and reduced resting
energy expenditure, leading to an increased risk for
obesity. These patients typically have reduced lean body
mass in the lower extremities, with increased abdominal
and lower extremity fat tissue accumulation (23–31).
More than 50% of children with SB have body mass index
(BMI) values greater than the 95th percentile (32). Adults
with SCI have been shown to have an increased
prevalence of obesity (33,34); however, minimal research
has been conducted to examine the relationship between
obesity and increased risk factors for adverse health
outcomes among adolescents with spinal cord dysfunc-
tion. Furthermore, paralysis was an exclusionary criterion
for performing blood pressure measurements and
collecting blood and urine samples in NHANES 2001–
2002 (35).
Since obese adolescents have a greater prevalence of
metabolic syndrome compared to nonobese adolescents
and a greater risk of ultimately developing early onset of
type 2 diabetes and cardiovascular disease, we hypoth-
esized that adolescents with spinal cord dysfunction due
to SB or SCI would exhibit a higher prevalence and
severity of metabolic syndrome than able-bodied adoles-
cents and that the prevalence of metabolic syndrome in
these adolescents would be associated with their obesity
status. We also sought to determine whether spinal cord
dysfunction that occurs congenitally (SB) increased the
incidence and severity of markers associated with
metabolic syndrome compared to spinal cord dysfunc-
tion acquired as a consequence of a SCI years after birth.
METHODS
Study Population
Fifty-four adolescents who have spinal cord dysfunction
with thoracic and upper lumbar paraplegia (34 due to SB
and 20 due to SCI, all of whom were more than 1 y post
injury) were recruited from specialty SB and SCI clinics at
our institution. All SB and SCI patients at our clinic were
asked to participate in this study. Although we used a
convenience sample of adolescents with spinal cord
dysfunction, the rate of obesity in our study is similar to
the rates of obesity in the general population of
adolescents with SCI and SB (36–39). Sixty able-bodied
adolescents were recruited from the community through
written advertisements and in person at the orientation
session of the Fit Teen Program at the University of
California Davis Medical Center prior to participating in
their weight loss program. We oversampled obese
controls (31.7% controls were obese compared to
17.1% in NHANES 2003–2004) to ensure groups of
adequate size to detect an effect due to obesity compared
to spinal cord dysfunction. Subjects were aged 11 to 20
years of age. Everyone who agreed to participate from the
clinic, community, or Fit Teen program was included in
the study unless excluded due to surgery within the past 4
months, cognitive impairment that would interfere with
testing procedures, inability to understand instructions in
English, known diabetes, medications for blood pressure
or cholesterol management, or pregnancy. The Institu-
tional Review Board for University of California at Davis
and at Shriners Hospitals of Northern California for
Children approved this study. Minors signed assent forms
that explained the procedures and their rights before,
during, and after the study. Written consent was also
obtained from a parent or guardian. Testing was
conducted in accordance with the approved protocol.
Procedures
The subjects visited the laboratory once after 12 hours of
fasting. They were instructed to avoid unusual physical
activity for the 24 hours prior to testing. Testing began
between 7 AM and 9 AM. Height or length was measured
to determine stature. Weight, waist circumference, and
percentage of trunk fat by DXA (Hologic QDR4500A,
version 11.2.1 Whole Body, Hologic, Bedford, MA) (40)
were measured as indices of obesity. The spine itself was
excluded from all scans so that subjects with and without
hardware would be compared equally. Waist circumfer-
ence was measured with a tape measure, snug without
binding, parallel to the ground, at the umbilicus. Blood
pressure was measured twice, with the appropriate
pediatric or adult size cuff fitted on the right arm, while
the subject was seated, after 30 minutes of rest. Height,
BMI, and blood pressure values were standardized to z-
scores to enable comparisons among different age
groups. BMI z-scores were calculated based on the LMS
formula proposed by Cole et al (41,42). To avoid
overstating hypertension in SB, we used 50th percentile
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for age in lieu of actual height percentile for subjects with
SB to determine z-scores for systolic blood pressure (43).
Fasting serum samples were analyzed for glucose, insulin,
TG, total cholesterol, HDL, and LDL concentrations.
Definitions of Metabolic Syndrome
Although several major studies have been conducted to
assess the prevalence of metabolic syndrome in pediatric
populations (44–46), there is no consensus for the cutoff
values used to classify metabolic syndrome. Nevertheless,
most studies appear to agree with classifying adolescents
as having metabolic syndrome if they have 3 of the
following criteria: obesity, insulin resistance/impaired
glucose tolerance, high blood pressure, high TG, and
low HDL. The values for obesity include a BMI z-score of
2.0 (97th percentile) adjusted for age and sex (45),
90th percentile BMI for age and sex, (46), total body fat
mass as determined by DXA 30% in males and 35% in
females (47), or a waist circumference of .90th
percentile (13). Previously proposed criteria for obesity
in adolescents with SB are 20% total body fat in males
and 25% total body fat in females (48) andþ2 root mean
square of the residual from the regression of skinfold
thickness and hydrostatic weighing (30). Insulin resis-
tance has been defined 3 ways; impaired glucose
tolerance based on a 2-hour postprandial blood glucose
between 140 and 200 mg/dL (45), fasting blood glucose
110 mg/dL (13,44,46), and fasting insulin 75th
percentile (49). Blood pressure has been indicated as
high with either systolic or diastolic blood pressure.90th
percentile for age, sex, and height (13,44,46), or with
.95th percentile for age and sex (45). Triglycerides were
considered high with 75th, (49) 90th (13,46), and 95th
percentiles (44,45). Low HDL has been indicated with
,5th (45), 10th (13,44), and 25th percentiles (49).
Therefore, given the lack of consensus, which makes
comparison between studies somewhat difficult, we
established the following criteria to determine risk factors
in this study, as shown in Table 1, that while unique to
our study, were based on Adult Treatment Panel III
Guidelines to metabolic syndrome adjusted for gender,
age, and puberty (44): abdominal adiposity for obesity
categories were represented as percent trunk fat 30.0%
for males and 35.0% for females (47); blood pressure
95th percentile for height, age, and gender; dyslipide-
mia with HDL concentrations ,45 mg/dL for males and
,50 mg/dL for females and/or triglyceride levels 100
mg/dL; insulin resistance or impaired glucose tolerance
represented as 1 of the following: fasting serum glucose
100 to 125 mg/dL, fasting serum insulin concentration
20 lU/mL, or the homeostasis model assessment of
insulin resistance (HOMA-IR) 4.0 (8,50–52).
We recognize that percent trunk fat is not the typical
criterion that is used to measure obesity in the pediatric
population; however, we believe that percent fat as
measured by DXA has advantages compared with other
indices of adiposity such as BMI and waist circumference
in the SCI and SB populations because their body habitus
has been shown to be significantly different from the
normative population (29,36,37,39,53–56). One limita-
tion with using DXA measured percent trunk fat is that it
does not differentiate between visceral and subcutaneous
adiposity; however, Svendsen et al found a correlation
between DXA trunk fat percent and CT abdominal fat (r¼
0.9) (57). Therefore, we studied the association between
percent trunk fat determined by DXA with both waist
circumference and BMI.
Biochemical Analysis
Serum glucose was measured using the Dade Behring
Glucose Oxidase method, and serum insulin was mea-
sured by chemiluminescence with a Bayer reagent (Tarry-
town, NY). HOMA-IR was calculated using the formula of
Matthews et al (58) HOMA-IR ¼ [(fasting plasma insulin
concentration (mU/mL)3 fasting plasma glucose (mmol/
L)]/22.5. Serum HDL, total cholesterol, and TG were
measured on a Beckman Coulter Synchron LX. LDL was
calculated according to the Friedewald Formula.
Statistical Analysis of Data
A 3-factor ANOVA was used to assess whether diagnosis
(CTRL, SCI, SB), obesity (nonobese ,30.0% trunk fat in
males and ,35.0% in females, obese 30.0% trunk fat in
males and 35.0% in females), or gender significantly
affected each of the components that comprise meta-
bolic syndrome. Nonsignificant interactions were re-
moved in a stepwise hierarchical fashion. HOMA-IR and
insulin were log transformed to conform to the normal
distribution. Comparisons of differences between groups
were made with post hoc tests using Tukey corrections.
ANOVA and regression analysis were done with SPSS
version 11.5 (SPSS, Chicago, IL). Chi-square analysis was
used to determine frequency of all nonparametric
measures including gender and age using Systat version
10 (SPSS, Chicago, IL).
RESULTS
Anthropometrics
The demographic and metabolic characteristics of the
obese and nonobese CTRL, SB, and SCI groups are shown
in Tables 2 and 3. The 3 groups were not significantly
different with respect to age (P¼ 0.548) and gender (P¼
0.643). There was a significant difference in body weight
between SB and CTRL, with SB weighing 14.6% less than
CTRL (P , 0.001), but no significant difference between
SCI and CTRL or between SB and SCI was observed. As
shown in Figure 1A and B, there was a high degree of
correlation between percent of trunk fat as determined
by DXA with both waist circumference (r2 ¼ 0.57 for
males; r2 ¼ 0.88 for females) and BMI (r2 ¼ 0.62 for
males; r2 ¼ 0.73 for females). Percent total body fat and
percent trunk fat as determined by DXA was significantly
different between each group, with SB averaging 6.3%
more trunk fat than SCI and 11.5% more trunk fat than
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CTRL (among all 3 groups, P , 0.001; and between SB
and SCI and between SB and CTRL, P¼0.004). Obese SCI
had been injured almost twice as long as nonobese SCI
subjects (P , 0.001). There was a gender effect, with
10.4% higher total fat in female than in male subjects (P,
0.001), and an interaction between diagnosis and obesity
(P¼0.018). Females had 10.1%more trunk fat percentage
than male subjects (P , 0.001). Height z-scores for SB
were 3.3 lower than those of control subjects (2.96 0.3 vs
0.4 6 0.1; P , 0.001) and 2.6 lower than for SCI (2.9 6
0.3 vs 0.3 6 0.4; P , 0.001). Consequently, BMI z-scores
were 0.7 higher in SB than CTRL and 1.36 higher in SB
than SCI (1.4 6 0.2 vs 0.7 6 0.1; P , 0.001 and 1.4 6
0.2 vs 0.1 6 0.5; P , 0.001, respectively).
Blood Pressure
As shown in Table 3, there was no diagnosis effect for
systolic blood pressure z-scores; however, there was a
significant obesity effect and no diagnosis–obesity
interaction effect. The systolic blood pressure z-scores
were significantly higher in obese groups as compared to
nonobese groups (overall 1.1 6 0.2 vs 0.0 6 0.2; P ,
0.001) and between SCI and SB when comparing
nonobese subjects only (0.7 6 0.6 vs 0.6 6 0.4; P ¼
0.0275).
Lipids
There were no significant differences in serum LDL
concentrations between groups; however, LDL was
13.3 mg/dL higher in obese subjects than in nonobese
subjects (113.0 6 3.8 mg/dL vs 99.7 6 2.9 mg/dL; P ¼
0.006). Similarly, while there were no differences in
serum triglyceride concentrations between SB, SCI, and
control groups (P ¼ 0.231), triglyceride levels averaged
26.2 mg/dL higher in obese than in nonobese subjects
(101.7 6 5.9 mg/dL vs 75.5 6 5.2 mg/dL; P ¼ 0.001).
Fasting TG was elevated in 26.5% of SB, 45.0% of SCI,
and 29.3% of control subjects. Serum HDL concentra-
tions were 8.5 mg/dL lower in SCI than in control
subjects (P ¼ 0.003), 6.2 mg/dL lower in obese groups
Table 1. Cutoff Criteria Used to Classify Metabolic Syndrome Risk Factors*
Abdominal
Adiposity Blood Pressure HDLz TG§
Impaired Glucose
Tolerance or Insulin
Resistancejj
Value % Trunk fat
30.0/35.0
males/females
95th percentile
for height, age,
and gender
,45/50 mg/dL
for males/females
100 mg/dL Fasting serum glucose
(FBG) 100–125 mg/dL
or
fasting blood insulin (FBI)
20 lU/mL
or
HOMA-IR 4.0
*HDL, high-density lipoprotein; TG, triglyceride; HOMA-IR, homeostasis model of insulin resistance.
Based on 85th percentile of percent fat mass.
zBased on 10th to 25th percentile in males and 10th to 15th percentile in females.
§Based on 85th to 95th percentile.
jjBased on American Diabetes Association recommendation for FBG, the level of FBI that suppressed lipolysis in adipose tissue by
50% (Gerald Reaven Sept 2000 Canadian Association of Cardiac Rehabilitation Interview).
Table 2. Demographics by Mobility Groups*
Characteristic (mean 6 SD) Control (n ¼ 60) SB (n ¼ 34) SCI (n ¼ 20)
Age, y 16.2 6 2.5 16.3 6 2.5 16.9 6 3.0
Gender, %
Female 55.0 47.1 45.0
Male 45.0 52.9 55.0
Ethnicity, %
Hispanic 10.0 21.0 15.0
African American 10.0 2.9 5.0
White 65.0 76.5 75.0
Asian American 15.0 0 5.0
Duration of injury, y . . . 16.3 6 2.5 4.8 6 4.0
*SB, spina bifida; SCI, spinal cord injury.
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(38.4 6 1.3 mg/dL vs 44.6 6 1.4 mg/dL; P¼0.001), and
5.1 mg/dL lower in males than in females (39.0 6 1.2
mg/dL vs 44.1 6 1.6 mg/dL; P¼ 0.002). Although mean
fasting serum HDL was lower in SB than in controls, as
shown in Table 3, the difference was not statistically
significant (P¼ 0.239); and the median values for HDL in
SB and SCI were similar. Fasting HDL concentrations were
lower than the cutoff in 73.5% of SB, 90.0% of SCI, and
67.2% of control subjects. There were no differences in
total serum cholesterol between diagnosis groups or
based on obesity; however, fasting serum total choles-
terol concentrations in male subjects averaged 17.9 mg/
dL lower than in female subjects (156.0 6 3.3 mg/dL vs
174.0 6 4.5 mg/dL; P ¼ 0.002).
Serum Glucose and Insulin Resistance
Overall, differences in fasting serum glucose concentra-
tions between SB and control groups were statistically
significant (P ¼ 0.012), although only 1 subject (obese
control) had glucose intolerance. Fasting serum glucose
was significantly lower in SB vs controls (P ¼ 0.011), but
fasting serum glucose was not significantly lower in SCI
subjects versus controls (P ¼ 0.222). Values for fasting
serum insulin concentrations and HOMA-IR were more
Table 3. Metabolic Components by Mobility Groups*
Characteristic (mean 6 SD) Control (n ¼ 60) SB (n ¼ 34) SCI (n ¼ 20)
BMI z-score 0.73 6 1.11 1.43 6 1.07 0.07 6 2.29z
(median) (0.72) (1.67) (0.59)
Height, in 65.8 6 4.3 57.0 6 4.5 64.2 6 5.8z
Height z-score 0.35 6 1.11 2.91 6 1.68 0.32 6 1.76
Weight, lb 156.2 6 50.5 133.4 6 30.8 142.4 6 48.5
DXA % trunk fat 25.7 6 12.8 37.2 6 9.6 30.9 6 13.4z
DXA % total body fat 28.0 6 11.2 40.0 6 8.5 33.9 6 12.5z
Systolic blood pressure z-score 0.53 6 1.27 1.00 6 1.03 0.15 6 1.88
Fasting serum glucose, mg/dL 88.9 6 6.5 84.9 6 6.3 86.2 6 5.9
Fasting serum insulin, lU/mL 10.8 6 7.9 10.6 6 5.4 12.9 6 9.4
HOMA-IR 2.4 6 1.8 2.2 6 1.2 2.8 6 2.1
HDL, mg/dL 44.2 6 10.8 40.8 6 11.0 35.7 6 7.4
(median) (41.0) (38.0) (36.5)
TG, mg/dL 87.7 6 46.0 84.3 6 39.6 94.4 6 42.4
(median) (78.0) (78.5) (86.5)
LDL, mg/dL 105.4 6 22.1 112.4 6 30.3 97.1 6 26.2
Total chol, mg/dL 167.2 6 29.7 170.3 6 32.9 151.6 6 28.2
*SB, spina bifida; SCI, spinal cord injury; BMI, body mass index; DXA, dual-energy x-ray absorptiometry; HOMA-IR, homeostasis
model assessment of insulin resistance; HDL, high-density lipoprotein; TG, triglyceride, LDL, low-density lipoprotein; chol,
cholesterol.
Significantly different from control value (P  0.05).
zSignificantly different from SB value (P  0.05).
Figure 1. Relationship of waist circumference to DXA % trunk fat (A). Male r2¼0.57 (P¼0.0018); y¼1.32x 20.76. Female r2¼0.88
(P ¼ 0.0017); y ¼ 1.26x  9.93. Relationship of BMI to DXA % trunk fat (B). Male r 2 ¼ 0.57 (P , 0.0001);
y ¼ 1.32x  20.76. Female r2 ¼ 0.88 (P , 0.0001); y ¼ 1.26x  9.93.
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than doubled in obese subjects compared to nonobese
subjects (15.8 6 1.1 lU/mL vs 6.9 6 0.5lU/mL for
insulin, P, 0.001; and 3.4 6 0.3 vs 1.5 6 0.1 for HOMA-
IR, P , 0.001). There was an interaction of diagnosis and
obesity for insulin (P ¼ 0.003) and for HOMA-IR (P ¼
0.004). Fasting insulin was elevated in 5.9% of SB, 30.0%
of SCI, and 10.3% of control subjects; and 8.8% of SB,
30.0% of SCI, and 17.2% of control subjects had high
HOMA-IR. Insulin and HOMA-IR correlated with systolic
blood pressure (r ¼ 0.227; P ¼ 0.006 and r ¼ 0.274; P ¼
0.006, respectively). HOMA-IR had a high correlation
with trunk fat percentage (r ¼ 0.614; P ,0.001).
Metabolic Syndrome
In our clinic population, 32% of SB subjects and 55.0% of
SCI subjects met the criteria established for metabolic
syndrome (3 risk factors/components) as shown in
Figure 2. Only 5.9% of SB and 5.0% of SCI subjects had
no components of metabolic syndrome, whereas 32.4%
of SB and 35.0% of SCI subjects had 1 risk factor and
61.8% of SB and 60.0% of SCI subjects had 2 risk factors
of metabolic syndrome. With the exception of only 2
subjects, those who had only 1 risk factor were not obese.
All 5 indicators of metabolic syndrome were significantly
affected by obesity, regardless of diagnostic group. As
shown in Table 6, 100% of the obese SCI subjects, 45.8%
of the obese SB subjects, and 63.2% of the obese CTRL
subjects met the criteria for metabolic syndrome. A 33 2
contingency table revealed that there was a strong
association between diagnostic group (SCI, SB, and
CTRL) and presence of metabolic syndrome (v2 ¼
0.012). The Fisher exact test demonstrated that the
obese SCI group had a significantly higher percentage of
subjects with metabolic syndrome than did the obese SB
group (P , 0.005) and approached significance when
compared to the CTRL group (P ¼ 0.063). In contrast,
there was no significant association between the
presence of metabolic syndrome and diagnostic group
in the nonobese subjects (P ¼ 0.396). Only 10% of the
nonobese SCI subjects, 0% of the nonobese SB subjects,
and 2.4% of the nonobese control subjects met the
criteria for metabolic syndrome. The most common 3 risk
factors observed in this study were increased trunk fat,
decreased fasting serum HDL concentration, and in-
creased fasting serum triglyceride concentration, as
shown in Table 5.
DISCUSSION
Our results represent the first known evidence that
adolescents with SCI or SB and obesity have an increased
prevalence of components of the metabolic syndrome,
similar to what has been reported in adults with spinal
cord injury (59,60) and able-bodied children with obesity
(10,45,47,61–65). This finding is significant given that the
occurrence of 3 components of the metabolic syn-
drome, documented in our study in many obese
adolescents with spinal cord dysfunction, is associated
with a threefold increased risk of developing cardiovascu-
lar disease and fivefold higher risk of developing diabetes,
in addition to other comorbidities of obesity/diabetes such
as diabetic neuropathy and nephropathy, polycystic ovary
syndrome, sleep apnea, hepatic steatosis, gallstones, and
certain types of cancer at an earlier age (11,66). Even
though the sample sizes are small, the data from this study
suggest that obese individuals with SCI have a significantly
higher risk of metabolic syndrome than either obese SB
subjects or obese able-bodied subjects do. The increased
association ofmetabolic syndrome in obese SCI subjects as
compared to obese SB subjects may be due to metabolic
adaptation in utero and/or during development for
subjects with SB. Although obese SCI subjects had a
greater prevalence of metabolic syndrome than obese SB
subjects, the importance of obesity in SB should not be
overlooked since there is an increased prevalence of
obesity among children with thoracic and upper lumbar
spinal cord dysfunction due to SB and SCI associated with
lower limb paralysis and loss of lean tissue in the lower
extremities (28,29,31,33,36,37,39,53–56,67), reduced
resting energy expenditure (28,67), increased sedentary
existence (68), and reduced fitness levels (69).
Obesity is the primary contributing factor for both
able-bodied adolescents and mobility-impaired adoles-
cents with SCI and SB to develop additional risk factors
in the constellation referred to as the metabolic
syndrome; however, determining the most appropriate
assessment of obesity is problematic in subjects with SCI
and SB. The loss of lower limb muscle mass and
segmental growth retardation of limbs due to paralysis,
increase in total body and trunk fat, increasing regional
and total body adiposity, and decreasing lean tissue
with age, as well as the occurrence of progressive
skeletal deformities in the lower limb and trunk, skew
BMI calculations, resulting in overestimation of BMI in
Figure 2. Prevalence of metabolic syndrome by group.
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nonobese SB and underestimation in SCI subjects
(29,70). Since percent trunk fat by DXA correlated well
against waist circumference as shown in Figure 1A, we
used the percent trunk fat as an indicator of central
adiposity for all subjects regardless of mobility status. As a
result, 74% of SB subjects and 50% of SCI subjects were
classified as overweight based on the percentage of trunk
fat when determining whether they met the criteria for
obesity, as opposed to only 52.9% and 25.0%, respec-
tively, based on BMI z-score. Seventy-five percent of SB
females were obese compared to 66.7% of SB males.
These results concur with those by Shurtleff and others
that in adolescence, female subjects with SB have
increased fat mass compared to male subjects with SB
(36,37,71). Total body fat is approximately 18% in
ambulatory SB in compared to 31% in nonambulatory
SB (29,31,56), and 58% of SB are obese (30). The finding
that paraplegic SCI subjects with greater amounts of total
body fat had longer duration of injury agrees with those
of Manns et al (59). The NHANES III disability survey
reported 30% increased prevalence of obesity in partic-
ipants with a disability (30% vs 23%) (72,73).
One hundred percent of obese SCI subjects and
45.8% of obese SB subjects in our study met the criteria
for metabolic syndrome (3 risk factors/components), as
compared to the reported 30% occurrence of metabolic
syndrome in overweight and obese adolescents from the
NHANES III data (13,44,45,72,73). Very low proportions
of nonobese subjects studied had all 5 components of the
metabolic syndrome (approximately 5% of SCI, 0% of SB,
and 3% of control subjects), comparable to 0% of able-
bodied children reported in NHANES III (13). SCI, SB, or
able-bodied adolescents who do not become obese have
a low likelihood of exhibiting components of the
metabolic syndrome. Regardless of the presence or
absence of spinal cord impairment, 10% of nonobese
subjects studied had 3 components of the metabolic
syndrome. It would be worth exploring in the future
whether complete vs incomplete injury to the spinal cord
as opposed to location of the injury itself accounts for the
different rates of metabolic syndrome in patients with
spinal cord dysfunction.
Risks associated with increased systolic blood pres-
sure in obese adolescent subjects have been previously
documented (74–77). Therefore, increased systolic blood
pressure observed in our obese subjects is of concern
because there is both increased incidence of hyperten-
sion and an increase in intimal–medial thickness in the
carotid arteries (77). Furthermore, the Muscatine Study
data, which tracked 754 children and adolescents (mean
age 15 y; range 8–18 y) into adulthood (mean age 44 y;
range 40–49 y) revealed increased systolic blood pressure
in adolescence persisted into adulthood, especially when
they remained obese as adults (76).
Studies of lipid profiles in disabled populations have
primarily been conducted in adults. Obesity with
dyslipidemia in 45% of adult SCI subjects has been
previously identified (78). Although SB adolescents in this
Table 6. Percent With Increased Risk Factors by Group*
Nonobese
Control
Obese
Control
Nonobese
SB
Obese
SB
Nonobese
SCI
Obese
SCI
0 Factors 29.3 0 20.0 0.0 10.0 0.0
1 Factor 48.8 5.3 70.0 16.7 70.0 0.0
2 Factors 19.5 31.6 10.0 37.5 10.0 0.0
 3 Factors 2.4 63.2 0.0 45.8 10.0 100.0
*SB, spina bifida; SCI, spinal cord injury.
Table 5. Percent of Individuals With Metabolic Syndrome Risk Factors by Group*
Nonobese
Control
Obese
Control
Nonobese
SB
Obese
SB
Nonobese
SCI
Obese
SCI
% Trunk fat 0.0 100.0 0.0 100.0 0.0 100.0
Blood pressure 12.2 26.3 10.0 29.2 20.0 30.0
HDL 56.1 84.2 70.0 75.0 80.0 100.0
TG 24.4 36.8 10.0 33.3 20.0 70.0
HOMA-IR 4.9 42.1 0.0 12.5 0.0 60.0
Fasting serum glucose 2.5 0.0 0.0 0.0 0.0 0.0
*SB, spina bifida; SCI, spinal cord injury; HDL, high-density lipoprotein; TG, triglyceride; HOMA-IR, homeostasis model assessment of
insulin resistance.
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study had decreased levels of HDL and increased levels of
LDL and total cholesterol compared to controls, the
differences were not statistically significant. Rendeli et al
also reported no significant differences in lipid profiles
between SB children and adolescents (ages 1–16 y) and
able-bodied controls (79). The trend towards decreased
HDL and increased TG observed in our spinal cord
dysfunction groups agrees with the results found in adult
neuromuscular disease patients by Aitkens and colleagues
(80). A higher proportion of their disabled group had
decreased HDL and increased systolic blood pressure
(80). They identified decreased HDL, increased BMI, and
increased TG as the top 3 risk factors in both their
disabled population and able-bodied control group. This
corresponds with the top 3 risk factors observed in our
study—increased percent trunk fat, decreased HDL, and
elevated TG—and is also consistent with the study of
overweight adolescents by de Ferranti et al (44). We
observed 74.0% SB, 90.0% SCI, and 65.0% of CTRL to
have decreased HDL and increased systolic blood
pressure. Values for fasting serum HDL concentrations
were lower in SCI than controls. Bauman et al observed
decreased HDL concentrations in SCI compared with
control subjects, with significant differences reported in
males, whites, and Hispanics, but not in females or
African Americans (81–84). SCI subjects in our study had
HDL values ,35 mg/dL at a rate of 35%, which
corresponded to 24 to 40% of SCI in studies by Bauman
et al. Forty-five percent of subjects with SCI in our study
had HDL 45 mg/dL. These results are similar to those of
Dopler-Nelson et al, who found that 49% of adults with
SCI had significantly increased TG and 30% had
decreased HDL (85). Since decreased HDL is an
independent risk factor for increased myocardial infarc-
tion in adulthood and appears to be due to immobiliza-
tion (82,86,87), these results further suggest that
adolescents with spinal cord dysfunction who develop
components of the metabolic syndrome will be at
increased risk for cardiovascular disease in adulthood.
Although normal fasting blood glucose was observed
in 99% of subjects in this study, they may still be at risk for
developing diabetes (10). SB, SCI, and able-bodied
subjects with documented type 1 or type 2 diabetes
were excluded from our study. It was perhaps surprising
that SB subjects had lower rates of insulin resistance than
SCI subjects based on HOMA-IR, given that SB are
disabled from birth and the percent trunk fat and percent
total body fat are similar in obese SB and obese SCI. It is
possible that the differences observed between SB and
SCI may be due to a higher proportion of visceral fat in
SCI subjects (88).
HOMA-IR level was not significantly different among
SB, SCI, and control subjects. These interpretations are
based on insulin values from 1 fasting time point and may
indicate a different outcome had they been based on a 2-
hour postprandial glucose load; however, HOMA-IR has
been indicated as a valid measure of impaired glucose
tolerance in lieu of a glucose challenge (8,89). Insulin
resistance in spinal cord dysfunction appears to be directly
related to denervation of skeletal muscle (90). There were
no SB or SCI subjects with glucose intolerance; however,
8.8% of SB, 30.0% of SCI, and 16.7% of controls had
hyperinsulinemia and/or insulin resistance based on
fasting insulin concentrations and/or HOMA-IR values,
even though known diabetes was an exclusion criterion.
This is approximately half the rate reported by Jones et al
in their study of 20 SCI male adults (78). The relationship
of HOMA-IR to BMI is inconsistent with that observed by
Bacha et al (r2 ¼ 0.308 in our study, compared to r2 ¼
0.73) (91). Associations between HOMA-IR and BMI z-
score and between HOMA-IR and systolic blood pressure
z-score were also reported by Arnlov et al (92). They
found that insulin resistance in younger adults with
normal BMI and blood pressure was predictive of future
hypertension. All of the SCI subjects in this study with
insulin resistance were obese with dyslipidemia. Obesity
in adolescence tracks into adulthood and consequently
increases the risk of developing metabolic syndrome.
Vanhala et al showed that of 30 adults with metabolic
syndrome, 93% were obese adults and 70% had been
obese as children (21). Fifty percent to 80% of overweight
children will remain overweight as adults (93,94).
Children with BMI 75th percentile followed for approx-
imately 12 years in the Bogalusa Heart Study had 11.7
times the rate of having metabolic syndrome as adults
(87). The number of risk factors in youth is predictive of
decreased carotid artery elasticity in adulthood, with
systolic blood pressure as an independent predictor (17).
This may account for the increased incidence of
cardiovascular disease as a leading cause of mortality in
SCI at a younger age than in the general population (95–
98). Most alarming is the overall pattern of the increased
risk in adolescence for developing complications due to a
more sedentary lifestyle and increased prevalence of
obesity at a younger age than in previous generations.
CONCLUSIONS
The results of this study document that subjects with SCI
or SB have a very high risk of having components of the
metabolic syndrome, and this increased risk is primarily
due to their increased prevalence of obesity. Obese able-
bodied subjects, obese SB subjects, and obese subjects
with SCI had high rates of abdominal adiposity as
assessed by percent trunk fat and body fat percentage,
and an increased number of components of the
metabolic syndrome, mainly low serum HDL concentra-
tions, high TG levels, and insulin resistance compared
with nonobese control, SB, and SCI subjects. In our
sample, the obese SCI subjects had a higher prevalence
of metabolic syndrome than the obese SB and obese
able-bodied subjects did. Prevention of obesity in
children with spinal cord dysfunction will likely be critical
to the avoidance of metabolic syndrome components
and the promotion of optimal health. Ideally, this should
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begin in infancy in SB and very soon after the occurrence
of a traumatic SCI. This early emphasis on health
promotion for children and adolescents with spinal cord
dysfunction will require nutrition education, modified
caloric intake to achieve a more optimal balance of
energy intake and energy expenditure, and exercise
including strengthening, aerobic exercise, and commu-
nity physical activity and recreation participation (69).
Prevention of obesity and management of metabolic
syndrome components among obese patients should be
a high priority in any rehabilitation program for children
and adolescents with spinal cord dysfunction.
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